Effect of obturator nerve block during transurethral resection of bladder tumors on the disease recurrence, progression and surgery outcomes.
Bladder cancer
Obturator nerve blockade
Tumor recurrence
Journal
International urology and nephrology
ISSN: 1573-2584
Titre abrégé: Int Urol Nephrol
Pays: Netherlands
ID NLM: 0262521
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
07
06
2023
accepted:
25
07
2023
medline:
9
10
2023
pubmed:
2
8
2023
entrez:
2
8
2023
Statut:
ppublish
Résumé
In our study, we aimed to evaluate the effect of the obturator nerve block (ONB) on the operation time, duration of hospital stay, complete resection, presence of muscle tissue in the pathology, second resection, recurrence, and progression, when applied in addition to spinal anesthesia in patients with primary bladder lateral wall tumor and Transurethral Resection of Bladder Tumor (TURBT) was planned. Seventy patients with bladder lateral wall tumors were included in the study. In addition, ONB was applied to 35 of the patients who underwent spinal anesthesia. The two groups were compared in terms of obturator reflex development, perforation, complete resection, presence of muscle tissue in pathology samples, need for second resection, need for second resection due to inadequate muscle tissue, and 1 year recurrence and progression rates. When the two groups were compared for obturator reflex and bladder perforation, both were found to be lower in the ONB group (p = 0.002, p = 0.198, respectively). The rate of complete resection and the presence of muscle tissue in the pathology samples were higher in the ONB group (p = 0.045, p = 0.034, respectively). The rates of second resection and second resection due to inadequate muscle tissue were found to be higher in the group without ONB (p = 0.015, p = 0.106, respectively). In the 1-year follow-up, the recurrence rate was significantly lower in the ONB group (p < 0.001), while there was no significant difference between the progression rates (p = 0.106). In our study, we found out that ONB applied in addition to spinal anesthesia increases the rate of complete and muscle tissue resection by decreasing the obturator reflex, and causes a significant reduction in the need for second resection and tumor recurrence.
Identifiants
pubmed: 37531039
doi: 10.1007/s11255-023-03727-6
pii: 10.1007/s11255-023-03727-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2765-2772Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F (2017) Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 71(1):96–108
doi: 10.1016/j.eururo.2016.06.010
pubmed: 27370177
Guey LT, García-Closas M, Murta-Nascimento C, Lloreta J, Palencia L, Kogevinas M et al (2010) Genetic susceptibility to distinct bladder cancer subphenotypes. Eur Urol 57(2):283–292
doi: 10.1016/j.eururo.2009.08.001
pubmed: 19692168
Ploeg M, Aben KK, Kiemeney LA (2009) The present and future burden of urinary bladder cancer in the world. World J Urol 27(3):289–293
doi: 10.1007/s00345-009-0383-3
pubmed: 19219610
pmcid: 2694323
Reuter VE (2006) The pathology of bladder cancer. Urology 67(3):11–17
doi: 10.1016/j.urology.2006.01.037
pubmed: 16530068
Hendricksen K, Witjes JA (2007) Treatment of intermediate-risk non–muscle-invasive bladder cancer (NMIBC). Eur Urol Suppl 6(14):800–808
doi: 10.1016/j.eursup.2007.04.008
Sylvester RJ, Van Der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49(3):466–477
doi: 10.1016/j.eururo.2005.12.031
pubmed: 16442208
Cheng L, Neumann RM, Weaver AL, Cheville JC, Leibovich BC, Ramnani DM et al (2000) Grading and staging of bladder carcinoma in transurethral resection specimens: correlation with 105 matched cystectomy specimens. Am J Clin Pathol 113(2):275–279
doi: 10.1309/94B6-8VFB-MN9J-1NF5
pubmed: 10664630
Babjuk M, Burger M, Compérat EM, Gontero P, Mostafid AH, Palou J et al (2019) European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)-2019 update. Eur Urol 76(5):639–657
doi: 10.1016/j.eururo.2019.08.016
pubmed: 31443960
Doluoglu OG, Yildiz AK, Kacan T, Bayburtluoglu V, Bektas M, Ozgur BC (2022) Efficacy of obturator nerve block during transurethral resection on non-muscle invasive intermediate and high risk lateral wall bladder tumours: a prospective randomized controlled study. Urol J 19(6):445–450
pubmed: 34952965
Erbay G, Akyol F, Karabakan M, Celebi B, Keskin E, Hirik E (2017) Effect of obturator nerve block during transurethral resection of lateral bladder wall tumors on the presence of detrusor muscle in tumor specimens and recurrence of the disease. Kaohsiung J Med Sci 33(2):86–90
doi: 10.1016/j.kjms.2016.11.006
pubmed: 28137416
Tekgül ZT, Divrik RT, Turan M, Konyalioglu E, Simsek E, Gönüllü M (2014) Impact of obturator nerve block on the short-term recurrence of superficial bladder tumors on the lateral wall. Urol J 11(1):1248–1252
pubmed: 24595932
Panagoda PI, Vasdev N, Gowrie-Mohan S (2018) Avoiding the obturator jerk during TURBT. Curr Urol 12(1):1–5
doi: 10.1159/000447223
pubmed: 30374273
pmcid: 6198773
Chen WM, Cheng CL, Yang CR, Chung V (2008) Surgical tip to prevent bladder perforation during transurethral resection of bladder tumors. Urology 72(3):667–668
doi: 10.1016/j.urology.2008.04.042
pubmed: 18597827
Rodríguez JG, Monzón AJ, Alvarez RCG, Laso CA, Gomez JF, Martinez JR et al (2005) An alternative technique to prevent obturator nerve stimulation during lateral bladder tumours transurethral resection. Actas Urol Esp 29(5):445–447
Yildirim I, Basal S, Irkilata HC, Murat Z, Goktas S, Dayanc M (2009) Safe resection of bladder tumors with plasma kinetic energy. Int J Hematol Oncol 32(1):232–236
Prentiss R, Harvey G, Bethard W, Boatwright D, Pennington R (1965) Massive adductor muscle contraction in transurethral surgery: cause and prevention; development of new electrical circuitry. J Urol 93(2):263–271
doi: 10.1016/S0022-5347(17)63757-1
pubmed: 14260880
Richards KA, Smith ND, Steinberg GD (2014) The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies. J Urol 191(6):1655–1664
doi: 10.1016/j.juro.2014.01.087
pubmed: 24518761
Bolat D, Aydogdu O, Tekgul ZT, Polat S, Yonguc T, Bozkurt IH et al (2015) Impact of nerve stimulator-guided obturator nerve block on the short-term outcomes and complications of transurethral resection of bladder tumour: a prospective randomized controlled study. Can Urol Assoc J 9(11–12):E780
doi: 10.5489/cuaj.3149
pubmed: 26600884
pmcid: 4639427
Kobayashi M, Takeyoshi S, Takiyama R, Seki E, Tsuno S, Hidaka S et al (1991) A report on 107 cases of obturator nerve block. Masui The Japanese Journal of Anesthesiology 40(7):1138–1143
pubmed: 1920790
Gasparich JP, Mason JT, Berger RE (1984) Use of nerve stimulator for simple and accurate obturator nerve block before transurethral resection. J Urol 132(2):291–293
doi: 10.1016/S0022-5347(17)49600-5
pubmed: 6737580
Salonia A, Suardi N, Crescenti A, Colombo R, Rigatti P, Montorsi F (2006) General versus spinal anesthesia with different forms of sedation in patients undergoing radical retropubic prostatectomy: results of a prospective, randomized study. Int J Urol 13(9):1185–1190
doi: 10.1111/j.1442-2042.2006.01524.x
pubmed: 16984550
Giraldi G, Montesano M, Sandorfi F, Iachini M, Orsi G (2019) Excess length of hospital stay due to healthcare acquired infections: methodologies evaluation. Ann Ig 31(5):507–516
pubmed: 31304530
Tatlisen A, Sofikerim M (2007) Obturator nerve block and transurethral surgery for bladder cancer. Minerva Urol Nefrol 59(2):137–141
pubmed: 17571049
Sharma D, Singh V, Agarwal N, Malhotra M (2017) Obturator nerve block in transurethral resection of bladder tumor: a comparative study by two techniques. Anesth Essays Res 11(1):101
doi: 10.4103/0259-1162.184613
pubmed: 28298765
pmcid: 5341669
Deng W, Zhang Q, Yao H (2022) A systematic review and meta-analysis comparing the safety and efficacy of spinal anesthesia and spinal anesthesia combined with obturator nerve block in transurethral resection of bladder tumors. Emerg Med Int. https://doi.org/10.1155/2022/8490462
doi: 10.1155/2022/8490462
pubmed: 36204335
pmcid: 9532140
Jancke G, Rosell J, Jahnson S (2012) Residual tumour in the marginal resection after a complete transurethral resection is associated with local recurrence in Ta/T1 urinary bladder cancer. Scand J Urol Nephrol 46(5):343–347
doi: 10.3109/00365599.2012.684700
pubmed: 22564077
Grimm M-O, Steinhoff C, Simon X, Spiegelhalder P, Ackermann R, Vögeli TA (2003) Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 170(2):433–437
doi: 10.1097/01.ju.0000070437.14275.e0
pubmed: 12853793
Mariappan P, Zachou A, Grigor KM (2010) Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol 57(5):843–849
doi: 10.1016/j.eururo.2009.05.047
pubmed: 19524354
Capogrosso P, Capitanio U, Ventimiglia E, Boeri L, Briganti A, Colombo R et al (2016) Detrusor muscle in TUR-derived bladder tumor specimens: can we actually improve the surgical quality? J Endourol 30(4):400–405
doi: 10.1089/end.2015.0591
pubmed: 26597334
Dalbagni G, Herr HW, Reuter VE (2002) Impact of a second transurethral resection on the staging of T1 bladder cancer. Urology 60(5):822–824
doi: 10.1016/S0090-4295(02)01920-9
pubmed: 12429307
Wijkström H, Norming U, Lagerkvist M, Nilsson B, Näslund I, Wiklund P (1998) Evaluation of clinical staging before cystectomy in transitional cell bladder carcinoma: a long-term follow-up of 276 consecutive patients. Br J Urol 81(5):686–691
doi: 10.1046/j.1464-410x.1998.00637.x
pubmed: 9634042